Smith, Graham & Co., Investment Advisors, LP EGRX Holdings History
Smith, Graham & Co., Investment Advisors, LP's Eagle Pharmaceuticals Inc Holding Summary
As of 2023-12-31, Smith, Graham & Co., Investment Advisors, LP held - shares of Eagle Pharmaceuticals Inc(EGRX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Smith, Graham & Co., Investment Advisors, LP now holds 0% of the outstanding Eagle Pharmaceuticals Inc(EGRX) stock.
The initial trade took place in 2019Q1. And since then Smith, Graham & Co., Investment Advisors, LP has made 10 purchases of EGRX, at an average price of $44.43, for a total of 372,608.00 shares. In addition, there have been 10 sales at an average price of $20.07 for 372,608.00 shares. Based on historical transaction data and EGRX's current price of $3.69, Smith, Graham & Co., Investment Advisors, LP's estimated gain on his EGRX holdings is $-9.08 Mil, reflecting a -54.82% gain to date.
Smith, Graham & Co., Investment Advisors, LP EGRX ($3.69) Holding Chart
Smith, Graham & Co., Investment Advisors, LP EGRX ($3.69) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
